Fremman to acquire a mortify stake in Palex from Ergon and Corpfin at a $452m valuation.

Fremman, an independent pan European private equity firm, agreed to acquire a mortify stake in Palex, a distributor of high value-added medtech equipment and solutions, from investment firms Ergon and Corpfin at a $452m valuation. “Since 2007, when the current management team joined the Company, we have relentlessly focused on delivering best-in-class service for the broad healthcare community, continuously bringing new solutions and entering into innovative therapeutic areas. Furthermore, we are proud to have integrated more than 10 acquisitions since 2016. We are very grateful and happy with the uncompromised support we have had from Ergon and Corpfin and thrilled about the next phase with Fremman as majority shareholder, where we will continue to further pursue growth opportunities in Iberia and abroad," Xavier Carbonell, Palex CEO.